Genomic sequencing identifies mutant 'drivers' of common brain tumor
(Dana-Farber Cancer Institute) Large-scale genomic sequencing has revealed two DNA mutations that appear to drive about 15 percent of meningiomas report Dana-Farber Cancer Institute and Broad Institute scientists. Experimental drugs that inhibit these mutant gene pathways are in clinical trials and have shown promising activity, the researchers said, suggesting that targeted therapies already in development or use may work against these specific meningiomas. (Source: EurekAlert! - Medicine and Health)
